Eotaxin and nitric oxide production as markers of inflammation in allergic cynomolgus monkeys

International Archives of Allergy and Immunology

Volumn 120, Issue 3, 1999, Pages 209-217

  Young, Simon S ^a   Ritacco, Gretchen ^a   Skeans, Susan ^a   Chapman, Richard W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergy; Asthma; Broncho alveolar lavage; Eotaxin; Nitric oxide; Primate; Pulmonary inflammation

Indexed keywords

DEXAMETHASONE; EOTAXIN; NITRIC OXIDE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRONCHOSCOPY; CONTROLLED STUDY; INFLAMMATORY CELL; LUNG LAVAGE; MALE; MONKEY; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0032752729     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024269     Document Type: Article

References (38)

1. Hamel R, McFarlane CS, Ford-Hutchinson AW: Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. J Appl Physiol 1986;61:2081-2087.
2. Weiszer I, Patterson R, Pruzansky JJ: Ascaris hypersensitivity in the rhesus monkey. J Allergy 1968;41:14-22.
3. Nagai H, Kondo M, Koda A, Nakamura S, Hashimoto M, Yanagihara Y, Daikoku M: Responses of isolated Japanese monkey tracheal muscle to allergic mediators. Int Arch Allergy Immunol 1992;98:70-76.
4. Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD: Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990;68:779-786.
5. Turner CR, Andresen CJ, Smith WB, Watson JW: Characterization of a primate model of asthma using anti-allergy/anti-asthma agents. Inflam Res 1996;45:239-245.
6. 4 antagonism in a primate model of asthma. J Clin Invest 1996;97:381-387.
7. Persson MG, Zetterstrom O, Argrenius V, Ihre E, Gustafsson LE: Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994;343:146-147.
8. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM: Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800-803.
9. Gundel RH, Wegner CD, Letts LG: Antigen-induced acute and late-phase responses in primates. Am Rev Resp Dis 1992;146:369-373.
10. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-1174.
11. Mould AW, Matthaei KI, Young IG, Foster PS: Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064-1071.
12. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
13. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang Juan, Kassam N, Smith H, Shi X, Gonzalo J-A, Newman W, Gutierrez-Ramos J-C, Mackay CR: Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996;97:604-612.
14. Ishii Y, Shirato M, Nomura A, Sakamoto t, Uchida Y, Ohtsuka M, Sagai M, Hasegawa S: Cloning of rat eotaxin: Ozone inhalation increases mRNA and protein expression of lungs of Brown Norway rats. Am J Physiol 1998;274:L171-L176.
15. Rothenberg ME, Luster AD, Leder P: Mouse eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995;92:8960-8964.
16. Amdur MO, Mead J: Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol 1958;192:364-368.
17. Haley PJ, Muggenburg BA, Rebar AH, Shopp GM, Bice DE: Bronchoalveolar lavage cytology in cynomolgus monkeys and identification of cytologic alterations following sequential saline lavage. Vet Pathol 1989;26:265-273.
18. Verleden GM, Dupont LJ, Lamont L, Buyse B, Delacroix M, Van Raemdonck D, Lerut T, Vanhaecke J, Demedts MG: Is there a role for measuring exhaled NO in lung transplant recipients with chronic rejection? J Heart Lung Transplant 1997;16:1186-1187.
19. Kharitonov SA, Yates D, Barnes PJ: Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-297.
20. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995;16:128-130.
21. Mehta S, Lilly CM, Rollenhagen JE, Haley KJ, Asano K, Drazen JM: Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am J Physiol 1997;272:L124-L131.
22. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1268-1270.
23. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-135.
24. Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E: Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med 1998;157:769-775.
25. Barnes PJ: Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 1998;94:557-572.
26. Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma: An update. Pharmacol Rev 1998;50:515-596.
27. Hedenstierne G, Högman M: Can exhaled NO be used as a marker of airway inflammation? Eur Respir J 1998;12:1248-1249.
28. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM: Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996;153:1510-1514.
29. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
30. Schedin U, Frostella C, Gustafsson LE: Nitric oxide occurs in high concentrations in monkey upper airways. Acta Physiol Scand 1995;155:473-474.
31. Therminarias A, Flore P, Favre-Juvin A, Oddou M-F, Delaire M, Grimbert F: Air contamination with nitric oxide. Am J Respir Crit Care Med 1998;157:791-795.
32. Kharitonov S, Alving K, Barnes PJ: Exhaled and nasal nitric oxide measurements: Recommendations. Eur Respir J 1997;10:1683-1693.
33. Persson MG, Gustaffson LE: Allergen-induced airway obstruction in guinea-pigs is associated with changes in nitric oxide levels in exhaled air. Acta Physiol Scand 1993;149:461-466.
34. Forssmann U, Uguccioni M, Loetscher P, Dahinhen CA, Langen H, Thelen M, Baggiolini M: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3 and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-2176.
35. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AEI, Wells TNC, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ: Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo. J Exp Med 1997;186:601-612.
36. Begin R, Rola-Pleszcynski M, Sirois P, Masse S, Nadeau D, Bureau MA: Sequential analysis of the bronchoalveolar milieu in conscious sheep. J Appl Physiol 1981;50:665-671.
37. Rothenburg ME, Owen WF, Silberstein DS, Soberman RJ, Austen F, Stevens RL: Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 1987;237:645-647.
38. Rothenburg ME: Eosinophilia. N Engl J Med 1998;338:1592-1600.